United Therapeutics Corporation Earnings Per Share (Diluted)
United Therapeutics Corporation (UTHR) reported Earnings Per Share (Diluted) of $7.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- United Therapeutics Corporation earnings per share, diluted for the quarter ending 2026-06-30 was $7.27, a 13.42% increase year-over-year.
- United Therapeutics Corporation earnings per share, diluted for the quarter ending 2026-03-31 was $5.82, a 12.22% decline year-over-year.
- United Therapeutics Corporation earnings per share, diluted for the quarter ending 2025-12-31 was $7.70, a 23.98% increase year-over-year.
- United Therapeutics Corporation earnings per share, diluted for the quarter ending 2025-09-30 was $7.16, a 12.05% increase year-over-year.
- United Therapeutics Corporation earnings per share, diluted for fiscal 2025 was $27.86, a 13.07% increase from fiscal 2024.
- United Therapeutics Corporation earnings per share, diluted for fiscal 2024 was $24.64, a 24.38% increase from fiscal 2023.
- United Therapeutics Corporation earnings per share, diluted for fiscal 2023 was $19.81, a 32.07% increase from fiscal 2022.
- United Therapeutics Corporation earnings per share, diluted for fiscal 2022 was $15.00, a 49.11% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.27 10-Q · filed 2026-08-05 | $13.07 10-Q · filed 2026-08-05 | $20.79 derived: net income ÷ weighted average shares · filed 2026-08-05 | $27.95 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | $5.82 10-Q · filed 2026-05-06 | $13.53 derived: net income ÷ weighted average shares · filed 2026-05-06 | $20.69 derived: net income ÷ weighted average shares · filed 2026-05-06 | $27.09 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $7.70 derived: net income ÷ weighted average shares · filed 2026-04-29 | $14.86 derived: net income ÷ weighted average shares · filed 2026-04-29 | $21.26 derived: net income ÷ weighted average shares · filed 2026-08-05 | $27.86 10-K · filed 2026-02-25 |
| 2025-09-30 | $7.16 10-Q · filed 2025-10-29 | $13.56 derived: net income ÷ weighted average shares · filed 2026-08-05 | $20.17 10-Q · filed 2025-10-29 | $26.40 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | $6.41 10-Q · filed 2026-08-05 | $13.02 10-Q · filed 2026-08-05 | $19.25 derived: net income ÷ weighted average shares · filed 2026-08-05 | $25.64 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | $6.63 10-Q · filed 2026-05-06 | $12.84 derived: net income ÷ weighted average shares · filed 2026-05-06 | $19.23 derived: net income ÷ weighted average shares · filed 2026-05-06 | $25.09 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | $6.21 derived: net income ÷ weighted average shares · filed 2026-04-29 | $12.60 derived: net income ÷ weighted average shares · filed 2026-04-29 | $18.46 derived: net income ÷ weighted average shares · filed 2026-04-29 | $24.64 10-K · filed 2026-02-25 |
| 2024-09-30 | $6.39 10-Q · filed 2025-10-29 | $12.25 derived: net income ÷ weighted average shares · filed 2025-10-29 | $18.43 10-Q · filed 2025-10-29 | $22.72 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-06-30 | $5.85 10-Q · filed 2025-07-30 | $12.03 10-Q · filed 2025-07-30 | $16.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | $21.72 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-03-31 | $6.17 10-Q · filed 2025-04-30 | $10.51 derived: net income ÷ weighted average shares · filed 2026-04-29 | $15.89 derived: net income ÷ weighted average shares · filed 2026-04-29 | $21.13 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-12-31 | $4.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | $9.72 derived: net income ÷ weighted average shares · filed 2026-04-29 | $14.96 derived: net income ÷ weighted average shares · filed 2026-04-29 | $19.81 10-K · filed 2026-02-25 |
| 2023-09-30 | $5.38 10-Q · filed 2024-10-30 | $10.62 derived: net income ÷ weighted average shares · filed 2024-10-30 | $15.48 10-Q · filed 2024-10-30 | $18.16 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-06-30 | $5.24 10-Q · filed 2024-07-31 | $10.08 10-Q · filed 2024-07-31 | $12.77 derived: net income ÷ weighted average shares · filed 2026-04-29 | $17.68 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2023-03-31 | $4.86 10-Q · filed 2024-05-01 | $7.54 derived: net income ÷ weighted average shares · filed 2026-04-29 | $12.44 derived: net income ÷ weighted average shares · filed 2026-04-29 | $14.88 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-12-31 | $2.67 derived: net income ÷ weighted average shares · filed 2026-04-29 | $7.57 derived: net income ÷ weighted average shares · filed 2026-04-29 | $10.00 derived: net income ÷ weighted average shares · filed 2026-04-29 | $15.00 10-K · filed 2025-02-26 |
| 2022-09-30 | $4.91 10-Q · filed 2023-11-01 | $7.34 derived: net income ÷ weighted average shares · filed 2023-11-01 | $12.35 10-Q · filed 2023-11-01 | $14.71 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-06-30 | $2.41 10-Q · filed 2023-08-02 | $7.43 10-Q · filed 2023-08-02 | $9.77 derived: net income ÷ weighted average shares · filed 2026-04-29 | $13.19 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2022-03-31 | $5.03 10-Q · filed 2023-05-03 | $7.37 derived: net income ÷ weighted average shares · filed 2026-04-29 | $10.78 derived: net income ÷ weighted average shares · filed 2026-04-29 | $14.43 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2021-12-31 | $2.34 derived: net income ÷ weighted average shares · filed 2026-04-29 | $5.76 derived: net income ÷ weighted average shares · filed 2026-04-29 | $9.40 derived: net income ÷ weighted average shares · filed 2026-04-29 | $10.06 10-K · filed 2024-02-21 |
| 2021-09-30 | $3.42 10-Q · filed 2022-11-02 | $7.07 derived: net income ÷ weighted average shares · filed 2022-11-02 | $7.72 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $3.65 10-Q · filed 2022-08-03 | $4.28 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $0.61 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $11.54 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $3.84 10-Q · filed 2021-11-03 | $6.25 derived: net income ÷ weighted average shares · filed 2021-11-03 | $9.37 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $2.41 10-Q · filed 2021-08-04 | $5.53 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $3.12 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $1.20 10-K · filed 2020-02-26 | -$2.39 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $3.01 10-Q · filed 2020-10-28 | $7.67 derived: net income ÷ weighted average shares · filed 2020-10-28 | -$3.59 10-Q · filed 2020-10-28 | |
| 2019-06-30 | $4.66 10-Q · filed 2020-07-29 | -$6.61 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | -$11.32 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | $1.48 10-K · filed 2020-02-26 | $13.39 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $2.42 10-K · filed 2020-02-26 | $11.91 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | $3.98 10-K · filed 2020-02-26 | $9.51 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $5.57 10-K · filed 2020-02-26 | |||
| 2017-12-31 | $0.43 10-K · filed 2019-02-27 | $9.31 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $6.27 10-K · filed 2019-02-27 | $8.83 10-Q · filed 2018-10-31 | ||
| 2017-06-30 | -$1.25 10-K · filed 2019-02-27 | $2.68 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $3.89 10-K · filed 2019-02-27 | |||
| 2016-12-31 | $2.43 10-K · filed 2018-02-21 | $15.25 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $3.50 10-K · filed 2018-02-21 | $12.76 10-Q · filed 2017-10-25 | ||
| 2016-06-30 | $4.39 10-K · filed 2018-02-21 | $9.24 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $4.84 10-K · filed 2018-02-21 | |||
| 2015-12-31 | $2.10 10-K · filed 2017-02-22 | $12.72 10-K · filed 2018-02-21 | ||
| 2015-09-30 | $9.24 10-K · filed 2017-02-22 | $10.58 10-Q · filed 2016-10-27 | ||
| 2015-06-30 | $1.91 10-K · filed 2017-02-22 | $1.57 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | -$0.36 10-K · filed 2017-02-22 | |||
| 2014-12-31 | $2.17 10-K · filed 2016-02-25 | $6.28 10-K · filed 2017-02-22 | ||
| 2014-09-30 | -$0.53 10-K · filed 2016-02-25 | $4.12 10-Q · filed 2015-10-27 | ||
| 2014-06-30 | $2.10 10-K · filed 2016-02-25 | $4.54 10-Q · filed 2015-07-28 | ||
| 2014-03-31 | $2.43 10-K · filed 2016-02-25 | |||
| 2013-12-31 | -$0.60 10-K · filed 2015-02-24 | $3.28 10-K · filed 2016-02-25 | ||
| 2013-09-30 | $1.17 10-K · filed 2015-02-24 | $3.90 10-Q · filed 2014-10-28 | ||
| 2013-06-30 | $1.52 10-K · filed 2015-02-24 | $2.71 10-Q · filed 2014-07-29 | ||
| 2013-03-31 | $1.19 10-K · filed 2015-02-24 | |||
| 2012-12-31 | $1.60 10-K · filed 2014-02-25 | $5.71 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $1.46 10-K · filed 2014-02-25 | $4.11 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | $1.34 10-K · filed 2014-02-25 | $2.63 10-Q · filed 2013-07-25 | ||
| 2012-03-31 | $1.29 10-K · filed 2014-02-25 | |||
| 2011-12-31 | $0.77 10-K · filed 2013-02-26 | $3.67 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $1.38 10-K · filed 2013-02-26 | $2.81 10-Q · filed 2012-11-01 | ||
| 2011-06-30 | $1.18 10-K · filed 2013-02-26 | $1.44 10-Q · filed 2012-07-26 | ||
| 2011-03-31 | $0.26 10-K · filed 2013-02-26 | |||
| 2010-12-31 | $0.15 10-K · filed 2012-02-28 | $1.78 10-K · filed 2013-02-26 | ||
| 2010-09-30 | $0.66 10-K · filed 2012-02-28 | $1.62 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | $0.62 10-K · filed 2012-02-28 | $0.95 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $0.32 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $0.35 10-K · filed 2012-02-28 | |||
| 2009-09-30 | $0.21 10-Q · filed 2010-10-28 | $0.41 10-Q · filed 2010-10-28 | ||
| 2009-06-30 | -$0.04 10-Q · filed 2010-07-28 | $0.20 10-Q · filed 2010-07-28 | ||
| 2008-12-31 | -$1.08 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |